Despite improved immune function in antiretroviral therapy (ART)-treated HIV-infected patients in low and middle-income countries, a significant proportion of patients with a new HIV diagnosis still present with advanced disease (CD4+ T cells < 200/μL) and are at risk for opportunistic infections (OI) such as cryptococcal meningitis [7]. This evidence concerns the gene CD4 and Cryptococcal meningitis.